Ozempic Ingredient Gives Novo Nordisk’s Kidney Trial A Positive Result: What It Means For Health Care – Novo Nordisk (NYSE:NVO) – Beragampengetahuan
Novo Nordisk A/S NVO shares got a boost this week after the drugmaker halted trials testing potential treatment for kidney failure on early signs of efficacy. The study has implications for other drugmakers including Eli Lilly And Co LLY and DaVita Inc DVA. What To Know: The Independent Data Monitoring Committee recommended Novo Nordisk cut its kidney outcomes trial FLOW short after interim analysis showed the […]